Sign up to save your podcasts
Or
Share Discussing RA: Baricitinib dose reduction and switching to bDMARDs vs JAKis
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Discussing RA: Baricitinib dose reduction and switching to bDMARDs vs JAKis
Join Professors Iain McInnes, Hans Bijlsma, and Peter Nash for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest updates in RA.
In this episode, they discuss two papers: baricitinib dose reduction in patients with RA achieving sustained disease control and switching to bDMARDs vs cycling among JAKis in patients with RA who are inadequate responders to JAKis.
View all episodes
By The Immune-Mediated Inflammatory Disease Forum
4.9
88 ratings
Join Professors Iain McInnes, Hans Bijlsma, and Peter Nash for the latest episode on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest updates in RA.
In this episode, they discuss two papers: baricitinib dose reduction in patients with RA achieving sustained disease control and switching to bDMARDs vs cycling among JAKis in patients with RA who are inadequate responders to JAKis.
More shows like The IMID Forum
View all
JAMA Editors' Summary
135 Listeners
NEJM This Week
321 Listeners
Lupus Science and Medicine Podcast
14 Listeners
Rheumnow Podcast
124 Listeners
Pod Save America
86,743 Listeners
The Curbsiders Internal Medicine Podcast
3,329 Listeners
The Daily
111,084 Listeners
Core IM | Internal Medicine Podcast
1,112 Listeners
The Evidence Based Rheumatology Podcast
114 Listeners
ACR on Air
69 Listeners
Rheumatology For The Royal College
174 Listeners
ACR Journals On Air
20 Listeners
The Rest Is Politics: Leading
860 Listeners
The Lupus Forum
0 Listeners
The Rest Is Politics: US
2,211 Listeners